Infection in critically ill pediatric patients on continuous renal replacement therapy

被引:14
|
作者
Santiago, Maria J. [1 ]
Lopez-Herce, Jesus [1 ]
Vierge, Eva [1 ]
Castillo, Ana [1 ]
Bustinza, Amaya [1 ]
Bellon, Jose M. [2 ]
Sanchez, Amelia [1 ]
Fernandez, Sarah [1 ]
机构
[1] Univ Complutense Madrid, Sch Med, Gregorio Maranon Gen Univ Hosp Madrid, Pediat Intens Care Dept,Hlth Res Inst, Madrid, Spain
[2] Univ Complutense Madrid, Sch Med, Gregorio Maranon Gen Univ Hosp Madrid, Dept Stat,Hlth Res Inst, Madrid, Spain
来源
关键词
Acute kidney injury; Continuous renal replacement therapy; Extracorporeal membrane oxygenation; Hemofiltration; Infection; RISK; CHILDREN; EPIDEMIOLOGY; DYSFUNCTION; INCREASE; FAILURE;
D O I
10.5301/ijao.5000587
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Introduction: Continuous renal replacement therapies (CRRT) are frequently used in critically ill children and may increase the risk of infection. However, the incidence, characteristics and prognosis of infection in critically ill children on CRRT have not been studied. Methods: Data from a prospective, single-center register of critically ill children treated with CRRT was analyzed. Results: 55 children (40% under 1 year of age) were treated with CRRT between June 2008 and January 2012; 43 patients (78.2%) presented 1 or more infections. The most common condition of patients requiring CRRT was heart disease (69%). Infection occurred a median of 11 days after the initiation of CRRT (IQ range: 4 to 21 days). A total of 21 patients (48.8 %) developed 1 infection, 7 (16.2%) developed 2 infections and 15 (34.9%) developed 3 or more infections. The most frequent infection was catheter-related bacteremia, with no differences in catheter location. CRRT duration longer than 4.5 days was the only risk factor for infection. Patients with infection had a longer length of stay (LOS) in the Pediatric Intensive Care Unit (PICU) than patients without it (37.8 vs. 17.6, p = 0.019), but there were no differences in mortality (30.2% vs. 33.3%; p = 0.84). Conclusions: Infection rate is high in critically ill children treated with CRRT. More than 4 days of CRRT increases the risk of infection. Infection in these patients entails a longer stay in the PICU but did not increase mortality.
引用
收藏
页码:224 / 229
页数:6
相关论文
共 50 条
  • [21] Alkalemia during continuous renal replacement therapy and mortality in critically ill patients
    Demirjian, Sevag
    Teo, Boon Wee
    Paganini, Emil P.
    [J]. CRITICAL CARE MEDICINE, 2008, 36 (05) : 1513 - 1517
  • [22] Association of Thrombocytopenia and Mortality in Critically Ill Patients on Continuous Renal Replacement Therapy
    Guru, Pramod K.
    Singh, Tarun D.
    Akhoundi, Abbasali
    Kashani, Kianoush B.
    [J]. NEPHRON, 2016, 133 (03) : 175 - 182
  • [23] Echinocandin Dosing in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
    Aguilar G.
    Ferriols R.
    Navarro D.
    Belda F.J.
    [J]. Current Fungal Infection Reports, 2017, 11 (1) : 1 - 4
  • [24] Pharmacokinetics of trimethoprim/sulfametrole in critically ill patients on continuous renal replacement therapy
    Welte, Rene
    Beyer, Rudolph
    Hotter, Johannes
    Broeker, Astrid
    Wicha, Sebastian G.
    Gasperetti, Tiziana
    Ranke, Paul
    Zaruba, Marc-Michael
    Lorenz, Ingo
    Eschertzhuber, Stephan
    Stroehle, Mathias
    Bellmann-Weiler, Rosa
    Joannidis, Michael
    Bellmann, Romuald
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (05) : 1237 - 1241
  • [25] Pharmacokinetics of cefepime during continuous renal replacement therapy in critically ill patients
    Malone, RS
    Fish, DN
    Abraham, E
    Teitelbaum, I
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (11) : 3148 - 3155
  • [26] Clearance of meropenem during continuous renal replacement therapy in critically ill patients
    F Thalhammer
    P Schenk
    H Burgmann
    UM Hollenstein
    K Ratheiser
    S Breyer
    [J]. Critical Care, 3 (Suppl 1):
  • [27] Micronutrient deficiencies in critically ill patients receiving continuous renal replacement therapy
    Fah, Megan
    Van Althuis, Laura E.
    Ohnuma, Tetsu
    Winthrop, Hilary M.
    Haines, Krista L.
    Williams, David G. A.
    Krishnamoorthy, Vijay
    Raghunathan, Karthik
    Wischmeyer, Paul E.
    [J]. CLINICAL NUTRITION ESPEN, 2022, 50 : 247 - 254
  • [28] Antimicrobial Treatment in Critically Ill Patients Requiring Continuous Renal Replacement Therapy
    Six, S.
    Gury, E.
    Nseir, S.
    [J]. REANIMATION, 2014, 23 (06): : 629 - 637
  • [29] Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
    J Solé Violan
    J Ferrer Agüero
    B Sádaba
    S Sancho
    R Zaragoza
    P Luque
    M Nieto
    M López
    F García
    C Hernández
    J Azanza
    [J]. Critical Care, 18 (Suppl 1):
  • [30] The incidence of thrombocytopenia associated with continuous renal replacement therapy in critically ill patients
    Ferreira, Jason A.
    Johnson, Donald W.
    [J]. RENAL FAILURE, 2015, 37 (07) : 1232 - 1236